2017 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
| Top rated | 11 of 44 |
| Best rating | 168 % |
| Worst rating | -2,028 % |
| New companies | |
| Negative Economic Capital Ratio | 15 of 44 |
Financial Strength Rankings using Artificial Intelligence
| Top rated | 11 of 44 |
| Best rating | 168 % |
| Worst rating | -2,028 % |
| New companies | |
| Negative Economic Capital Ratio | 15 of 44 |
| Revenues | 24.9 B |
| Assets | 34.1 B |
| Expenses | 24.5 B |
| Stockholders Equity | 12.0 B |
| Unprofitable Companies | 26 of 44 |

This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai